p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitorAime A. Levesque(University of Hartford), Clara Angeles(University of Hartford)PLoS ONEFebruary 10, 202210.1371/journal.pone.0263463Cited by 2SaveCiteExport RISWatch citationsRelated Papersp53 Dimers Associate with a Head-to-Tail Response Element to Repress Cyclin B Transcription|PLoS ONE|2012|20